Matches in Nanopublications for { ?s ?p "[Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1175694.RAB9Z3g6Q2ofhXkjNOPd-ZMqJPOL3zZlq47aJDlSFcV6c130_assertion description "[Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175694.RAB9Z3g6Q2ofhXkjNOPd-ZMqJPOL3zZlq47aJDlSFcV6c130_provenance.
- NP1175693.RA6wdHrcl85fs4SuS1rtwII0BTLuwyVkifNE6a3EbST_Y130_assertion description "[Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175693.RA6wdHrcl85fs4SuS1rtwII0BTLuwyVkifNE6a3EbST_Y130_provenance.